Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
Cell|September 18, 2012
Genomic landscape of non-small cell lung cancer in smokers and never-smokersRamaswamy Govindan, Li Ding, Malachi Griffith, et al.The Lancet. Oncology|April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trialRebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.Cell Reports. Medicine|September 19, 2023
Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancerSyeda Maheen Batool, Tiffaney Hsia, Alexandra Beecroft, et al.JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.Journal of the National Cancer Institute|January 7, 2026
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)Marie Wood, Paul F Pinsky, Paul Novotny, et al.Journal of Clinical Pharmacology|May 2, 2003
Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe WorkshopLawrence J Lesko, Ronald A Salerno, Brian B Spear, et al.Molecular and Cellular Biology|August 26, 2009
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumorsMark Watson, Anne Roulston, Laurent Bélec, et al.The Journal of Allergy and Clinical Immunology|February 19, 2019
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptomsKatherine C Konvinse, Jason A Trubiano, Rebecca Pavlos, et al.Blood|December 28, 2007
Identification of somatic JAK1 mutations in patients with acute myeloid leukemiaZhifu Xiang, Yu Zhao, Vesselin Mitaksov, et al.Nature|September 1, 2022
Comprehensive evidence implies a higher social cost of CO2Kevin Rennert, Frank Errickson, Brian C Prest, et al.Pageof 13